BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28027668)

  • 1. Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada.
    Rachlis B; Burchell AN; Gardner S; Light L; Raboud J; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; Wobeser W; McGee F; Rachlis A; Rourke SB;
    AIDS Care; 2017 Jul; 29(7):828-837. PubMed ID: 28027668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the association between stress and antiretroviral therapy adherence among women living with HIV in Toronto, Ontario.
    Benoit AC; Burchell AN; O'Brien KK; Raboud J; Gardner S; Light L; Beaver K; Cotnam J; Conway T; Price C; Rourke SB; Rueda S; Hart TA; Loutfy M;
    HIV Res Clin Pract; 2020; 21(2-3):45-55. PubMed ID: 32419657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High retention in HIV care at a tertiary care centre in Toronto, Canada.
    Szadkowski L; Walmsley S; Burchell AN; Collins E; Rourke SB; Raboud J;
    AIDS Care; 2018 Feb; 30(2):246-254. PubMed ID: 28678619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011.
    Burchell AN; Gardner S; Light L; Ellis BM; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; McGee F; Raboud J; Rachlis A; Wobeser W; Rourke SB
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e10-9. PubMed ID: 26322672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
    Tanner Z; Lachowsky N; Ding E; Samji H; Hull M; Cescon A; Patterson S; Chia J; Leslie A; Raboud J; Loutfy M; Cooper C; Klein M; Machouf N; Tsoukas C; Montaner J; Hogg RS;
    BMC Infect Dis; 2016 Oct; 16(1):590. PubMed ID: 27769246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS).
    Rourke SB; Gardner S; Burchell AN; Raboud J; Rueda S; Bayoumi AM; Loutfy M; Cooper C; Smieja M; Taylor D; DiPede T; Wobeser W; Major C; Waring V; Fisher M; Cairney J; Mittmann N; Salit IE; Crouzat F; Gough K; Ralph E; Sandre R; Kilby D; Rachlis A
    Int J Epidemiol; 2013 Apr; 42(2):402-11. PubMed ID: 22345312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.
    Rebeiro PF; Abraham AG; Horberg MA; Althoff KN; Yehia BR; Buchacz K; Lau BM; Sterling TR; Gange SJ
    AIDS Patient Care STDS; 2017 Mar; 31(3):129-144. PubMed ID: 28282246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study.
    Raboud J; Su D; Burchell AN; Gardner S; Walmsley S; Bayoumi AM; Blitz S; Cooper C; Salit I; Cohen J; Rourke SB; Loutfy MR
    BMC Med Res Methodol; 2013 Mar; 13():31. PubMed ID: 23496868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of drug coverage on viral suppression among people living with HIV in Ontario, Canada.
    Rachlis B; Light L; Gardner S; Burchell AN; Raboud J; Kendall C; McIsaac MA; Murray J; Rachlis A; Rourke SB
    Can J Public Health; 2018 Dec; 109(5-6):800-809. PubMed ID: 30140981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
    Cescon A; Patterson S; Davey C; Ding E; Raboud JM; Chan K; Loutfy MR; Cooper C; Burchell AN; Palmer AK; Tsoukas C; Machouf N; Klein MB; Rourke SB; Rachlis A; Hogg RS; Montaner JS;
    J Int AIDS Soc; 2015; 18(1):20024. PubMed ID: 26443752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily dosing improves adherence to antiretroviral therapy.
    Raboud J; Li M; Walmsley S; Cooper C; Blitz S; Bayoumi AM; Rourke S; Rueda S; Rachlis A; Mittmann N; Smieja M; Collins E; Loutfy MR
    AIDS Behav; 2011 Oct; 15(7):1397-409. PubMed ID: 20878227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
    Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
    BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study.
    Bucciardini R; Fragola V; Abegaz T; Lucattini S; Halifom A; Tadesse E; Berhe M; Pugliese K; Binelli A; De Castro P; Terlizzi R; Fucili L; Di Gregorio M; Mirra M; Olivieri E; Teklu T; Zegeye T; Haile A; Vella S; Abraham L; Godefay H;
    PLoS One; 2015; 10(9):e0136117. PubMed ID: 26340271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Syphilis Coinfection Is Not Associated With an Increased Risk of Virologic Failure Among HIV-Positive Men Who Have Sex With Men on Antiretroviral Therapy.
    Grewal R; Allen VG; Bayoumi AM; Gardner SL; Kaul R; Mazzulli T; Moravan V; OʼNeill T; Raboud J; Rourke SB; Tan DHS; Burchell AN;
    J Acquir Immune Defic Syndr; 2019 Apr; 80(5):585-589. PubMed ID: 30730358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
    Wolff MJ; Cortes CP; Mejìa FA; Padgett D; Belaunzarán-Zamudio P; Grinsztejn B; Giganti MJ; McGowan CC; Rebeiro PF;
    Int J STD AIDS; 2018 Jan; 29(1):4-12. PubMed ID: 28618980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.